Clinic
Delta Medical Group
Delta Medical Group was paid $7.71M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoDELTA MEDICAL GROUP
HOUMA, LA 70363
HOUMA, LA 70363
33aNPI1205210838assigned 07/14/2015
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.71M
24GClaims224,256
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Louisiana
Rank by total paid#13 of 98
Median peer was paid$694K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,181 | $424K | |
| 2019 | 17,733 | $809K | |
| 2020 | 20,199 | $788K | |
| 2021 | 30,177 | $1.22M | |
| 2022 | 45,763 | $1.59M | |
| 2023 | 55,498 | $1.61M | |
| 2024incomplete | 45,705 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 54,855 | 50,452 | $3.04M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 17% | 16,468 | 15,112 | $1.35M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 9.5% | 26,591 | 23,825 | $733K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.6% | 11,899 | 4,557 | $589K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.2% | 47,101 | 21,157 | $477K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.3% | 11,671 | 10,699 | $409K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.4% | 11,311 | 9,083 | $339K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.8% | 2,200 | 1,918 | $217K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.6% | 3,922 | 3,610 | $201K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 18,390 | 15,655 | $177K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 1,114 | 1,052 | $81K |
| 99205 | Prolong outpt/office vis | <1% | 375 | 346 | $38K |
10 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,313 | $35K |
| 87428 | <1% | 195 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,499 | $4K |
| 0240U | <1% | 32 | $4K | |
| 81003 | <1% | 2,285 | $3K | |
| 81025 | <1% | 550 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 56 | $2K |
| 87807 | <1% | 333 | $2K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 47 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 49 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTRANEY, MICHAEL (OWNER/PARTNER)